Why the study?
Does preadmission insulin-treated diabetes mellitus status increase long-term mortality in STEMI patients treated with primary PCI compared to non-insulin-treated or non-diabetic patients?
Does preadmission insulin-treated diabetes mellitus status increase long-term mortality in STEMI patients treated with primary PCI compared to non-insulin-treated or non-diabetic patients?
In STEMI patients undergoing primary PCI, insulin-treated diabetes is a strong independent predictor of long-term mortality, whereas non-insulin-treated diabetes has a mortality risk comparable to non-diabetics after age and gender adjustment.
No takes yet. Share an insight, caveat, or question.
ITDM signals higher long-term mortality post-PCI warranting closer monitoring; leaves open causality versus confounders in this observational cohort.
Hoebers et al. (2014) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: